Charles River Labs Q1 Earnings Beat Estimates but Lowers FY2026 Forecast
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 08 2026
0mins
Source: Newsfilter
Charles River Laboratories' stock fell 5.01% as it hit a 5-day low amid mixed market conditions.
The company reported Q1 earnings that exceeded estimates, indicating strong performance in the biopharmaceutical services sector. However, it lowered its FY2026 forecast due to uncertainties in the market environment, which may impact long-term investor confidence. Despite this, analysts maintained a positive outlook and raised price targets, suggesting strong market confidence in the company's future development.
The implications of the earnings report and forecast cut suggest a complex situation for Charles River Laboratories, as short-term investor reactions may be influenced by the positive earnings beat, while long-term growth prospects remain uncertain.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CRL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CRL
Wall Street analysts forecast CRL stock price to rise
12 Analyst Rating
9 Buy
3 Hold
0 Sell
Strong Buy
Current: 182.340
Low
185.00
Averages
226.70
High
265.00
Current: 182.340
Low
185.00
Averages
226.70
High
265.00
About CRL
Charles River Laboratories International, Inc. is a drug development company. It provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Mixed Performance in US Stock Indices, Chipmakers Lead Gains
- Strong Economic Data: US May retail sales rose 0.9% month-over-month, exceeding expectations of 0.6%, indicating resilient consumer demand that could positively impact future spending and economic recovery.
- Housing Market Recovery: Pending home sales in May increased by 3.8% month-over-month, significantly surpassing the expected 0.9%, marking the largest gain in 20 months, suggesting a rebound in the real estate market that may stimulate growth in related sectors.
- Oil Price Volatility: The agreement between the US and Iran to reopen the Strait of Hormuz has driven crude oil prices down to a 3.5-month low, increasing risk-on sentiment in the market, which may lead investors to reassess the risks and returns of energy-related assets.
- FOMC Meeting Focus: The market anticipates that the Federal Reserve will keep interest rates unchanged, but the press conference by new Chair Kevin Warsh will be pivotal, as investors closely watch his outlook on inflation to guide future investment decisions.
See More
U.S. Stocks Rise, Led by Chipmakers Amid Strong Retail Sales
- Strong Market Performance: The S&P 500 index rose by 0.23%, the Dow Jones Industrial Average increased by 0.26%, and the Nasdaq 100 climbed by 0.74%, reflecting market confidence in economic recovery, particularly driven by strong performances from chipmakers.
- Retail Sales Exceed Expectations: U.S. May retail sales increased by 0.9% month-over-month, surpassing the expected 0.6%, indicating resilient consumer demand that could further stimulate economic growth and influence future monetary policy.
- Oil Price Decline Affects Market Sentiment: The agreement between the U.S. and Iran to reopen the Strait of Hormuz has led to crude oil prices dropping to a 3.5-month low, enhancing risk-on sentiment in the markets and contributing to stock gains.
- FOMC Meeting in Focus: Market participants are closely watching the outcome of the FOMC meeting, where interest rates are expected to remain unchanged, but the guidance from new Chair Kevin Warsh will significantly impact market sentiment.
See More
Morgan Stanley Upgrades Charles River, Downgrades IQVIA Amid Biopharma Funding Boost
- Charles River Upgrade: Morgan Stanley upgraded Charles River Laboratories (CRL) from Equal Weight to Overweight, anticipating that increased biopharma funding will drive RFPs and bookings, reflecting market confidence in its preclinical research capabilities.
- Rising Safety Testing Demand: The analyst noted that while AI may impact the company's discovery activities, the demand for CRL's safety testing is expected to rise significantly as pharma pipelines become smarter, lowering barriers to market entry.
- IQVIA Downgrade: Morgan Stanley downgraded IQVIA (IQV) from Overweight to Equal Weight and lowered its price target from $225 to $200, primarily due to a lack of clarity on catalysts that could enhance its performance relative to peers.
- Limited EPS Growth: Although IQVIA's EPS growth since 2022 has largely been driven by share buybacks, the analyst remains cautious about its future sustainable growth, citing uncertainty regarding AI's impact on its narrative.
See More
Latest Wall Street Ratings Overview
- GE Vernova Rating: Bernstein initiates GE Vernova as outperform, citing the potential for U.S. natural gas to displace coal globally, thereby reducing electricity costs and providing reliable power, which could drive the stock price higher.
- NeoVolta Buy Rating: Needham initiates coverage on NeoVolta with a Buy rating and an $8 price target, indicating significant upside potential for the battery company, reflecting strong market demand for its products.
- Nvidia Outlook: Bernstein reiterates Nvidia as outperform, emphasizing the enormous and still early data center market opportunity, suggesting that the company's leadership in technology will continue to drive stock price growth.
- Allegiant Acquisition Boost: Goldman Sachs reinstates Allegiant as a Buy with a $125 price target, believing that the acquisition of Sun Country will provide incremental profitable growth opportunities, enhancing the company's competitive position in the market.
See More
Major Wall Street Rating Changes Overview
- Dell Upgrade: Susquehanna upgraded Dell from neutral to positive, citing increased confidence in a sustainable 8-10% operating margin and a 6% free cash flow margin, which supports a potential rerating of its EV/sales multiple to 3x, indicating strong market potential.
- Viper Energy Initiation: RBC initiated coverage of Viper Energy with an Outperform rating and a $58 price target, highlighting its advantages in scale and core Permian focus, positioning it as a best-in-class mineral and royalty company.
- SentinelOne Buy Rating: Bank of America upgraded SentinelOne from neutral to buy, viewing its solid quarterly performance as a strong entry point after an 18% decline in after-hours trading, reflecting confidence in its future growth prospects.
- XPeng Upgrade: Macquarie upgraded XPeng from neutral to outperform, noting its volume growth in the Chinese EV market, while future investments in humanoids and robotaxis provide additional upside potential for its stock.
See More
Cold Chain Monitoring Market Expands Rapidly
- Market Size Growth: According to Valuates Reports, the global cold chain monitoring market was valued at $7.414 billion in 2025 and is projected to reach $15.39 billion by 2032, with a CAGR of 11.2%, indicating strong market demand and investment potential.
- Technology-Driven Transformation: As the demand for compliance and quality increases, companies are transitioning from basic temperature logging systems to advanced connected monitoring solutions, which not only enhance transparency in transportation and storage but also improve management capabilities for temperature-sensitive products, reducing financial losses and compliance risks.
- Rising Hardware Demand: Cold chain monitoring relies on reliable sensors and data logging devices, with increasing market demand for these hardware components, particularly in the pharmaceutical and food sectors, ensuring the safety and quality of high-value shipments and driving continuous deployment of equipment.
- Last-Mile Challenges: Last-mile delivery has become a significant growth factor for the cold chain monitoring market, as monitoring systems assist logistics teams in tracking shipment conditions and triggering alerts, ensuring product quality is maintained until delivery to the final customer, meeting the growing demands of home healthcare and e-commerce.
See More
Mixed Performance in US Stock Indices, Chipmakers Lead Gains
- Strong Economic Data: US May retail sales rose 0.9% month-over-month, exceeding expectations of 0.6%, indicating resilient consumer demand that could positively impact future spending and economic recovery.
- Housing Market Recovery: Pending home sales in May increased by 3.8% month-over-month, significantly surpassing the expected 0.9%, marking the largest gain in 20 months, suggesting a rebound in the real estate market that may stimulate growth in related sectors.
- Oil Price Volatility: The agreement between the US and Iran to reopen the Strait of Hormuz has driven crude oil prices down to a 3.5-month low, increasing risk-on sentiment in the market, which may lead investors to reassess the risks and returns of energy-related assets.
- FOMC Meeting Focus: The market anticipates that the Federal Reserve will keep interest rates unchanged, but the press conference by new Chair Kevin Warsh will be pivotal, as investors closely watch his outlook on inflation to guide future investment decisions.
See More
U.S. Stocks Rise, Led by Chipmakers Amid Strong Retail Sales
- Strong Market Performance: The S&P 500 index rose by 0.23%, the Dow Jones Industrial Average increased by 0.26%, and the Nasdaq 100 climbed by 0.74%, reflecting market confidence in economic recovery, particularly driven by strong performances from chipmakers.
- Retail Sales Exceed Expectations: U.S. May retail sales increased by 0.9% month-over-month, surpassing the expected 0.6%, indicating resilient consumer demand that could further stimulate economic growth and influence future monetary policy.
- Oil Price Decline Affects Market Sentiment: The agreement between the U.S. and Iran to reopen the Strait of Hormuz has led to crude oil prices dropping to a 3.5-month low, enhancing risk-on sentiment in the markets and contributing to stock gains.
- FOMC Meeting in Focus: Market participants are closely watching the outcome of the FOMC meeting, where interest rates are expected to remain unchanged, but the guidance from new Chair Kevin Warsh will significantly impact market sentiment.
See More
Morgan Stanley Upgrades Charles River, Downgrades IQVIA Amid Biopharma Funding Boost
- Charles River Upgrade: Morgan Stanley upgraded Charles River Laboratories (CRL) from Equal Weight to Overweight, anticipating that increased biopharma funding will drive RFPs and bookings, reflecting market confidence in its preclinical research capabilities.
- Rising Safety Testing Demand: The analyst noted that while AI may impact the company's discovery activities, the demand for CRL's safety testing is expected to rise significantly as pharma pipelines become smarter, lowering barriers to market entry.
- IQVIA Downgrade: Morgan Stanley downgraded IQVIA (IQV) from Overweight to Equal Weight and lowered its price target from $225 to $200, primarily due to a lack of clarity on catalysts that could enhance its performance relative to peers.
- Limited EPS Growth: Although IQVIA's EPS growth since 2022 has largely been driven by share buybacks, the analyst remains cautious about its future sustainable growth, citing uncertainty regarding AI's impact on its narrative.
See More
Latest Wall Street Ratings Overview
- GE Vernova Rating: Bernstein initiates GE Vernova as outperform, citing the potential for U.S. natural gas to displace coal globally, thereby reducing electricity costs and providing reliable power, which could drive the stock price higher.
- NeoVolta Buy Rating: Needham initiates coverage on NeoVolta with a Buy rating and an $8 price target, indicating significant upside potential for the battery company, reflecting strong market demand for its products.
- Nvidia Outlook: Bernstein reiterates Nvidia as outperform, emphasizing the enormous and still early data center market opportunity, suggesting that the company's leadership in technology will continue to drive stock price growth.
- Allegiant Acquisition Boost: Goldman Sachs reinstates Allegiant as a Buy with a $125 price target, believing that the acquisition of Sun Country will provide incremental profitable growth opportunities, enhancing the company's competitive position in the market.
See More
Major Wall Street Rating Changes Overview
- Dell Upgrade: Susquehanna upgraded Dell from neutral to positive, citing increased confidence in a sustainable 8-10% operating margin and a 6% free cash flow margin, which supports a potential rerating of its EV/sales multiple to 3x, indicating strong market potential.
- Viper Energy Initiation: RBC initiated coverage of Viper Energy with an Outperform rating and a $58 price target, highlighting its advantages in scale and core Permian focus, positioning it as a best-in-class mineral and royalty company.
- SentinelOne Buy Rating: Bank of America upgraded SentinelOne from neutral to buy, viewing its solid quarterly performance as a strong entry point after an 18% decline in after-hours trading, reflecting confidence in its future growth prospects.
- XPeng Upgrade: Macquarie upgraded XPeng from neutral to outperform, noting its volume growth in the Chinese EV market, while future investments in humanoids and robotaxis provide additional upside potential for its stock.
See More
Cold Chain Monitoring Market Expands Rapidly
- Market Size Growth: According to Valuates Reports, the global cold chain monitoring market was valued at $7.414 billion in 2025 and is projected to reach $15.39 billion by 2032, with a CAGR of 11.2%, indicating strong market demand and investment potential.
- Technology-Driven Transformation: As the demand for compliance and quality increases, companies are transitioning from basic temperature logging systems to advanced connected monitoring solutions, which not only enhance transparency in transportation and storage but also improve management capabilities for temperature-sensitive products, reducing financial losses and compliance risks.
- Rising Hardware Demand: Cold chain monitoring relies on reliable sensors and data logging devices, with increasing market demand for these hardware components, particularly in the pharmaceutical and food sectors, ensuring the safety and quality of high-value shipments and driving continuous deployment of equipment.
- Last-Mile Challenges: Last-mile delivery has become a significant growth factor for the cold chain monitoring market, as monitoring systems assist logistics teams in tracking shipment conditions and triggering alerts, ensuring product quality is maintained until delivery to the final customer, meeting the growing demands of home healthcare and e-commerce.
See More
